基态人类干细胞促进再生医学和人类发展的研究
|
By LabMedica International staff writers Posted on 03 Dec 2013 |
|
发现了一种维持人类诱导多能干细胞（iPS 细胞）最早期、最原始、最基态的方法，预期该方法能促进这些干细胞在再生医学、患者特定 iPS 细胞疾病模型，以及在早期人类发展的体外和体内研究中的应用。
诱导多能干细胞形成的方法通常为：向诸如皮肤细胞的此类成人细胞基因组中插入 4 个基因，然后使用鸡尾酒式组合的生长因子培养改良的细胞。然后分化的细胞还原为胚胎干细胞类似状态，而不是成为多种不同细胞类型的成熟细胞。此问题的症结在于，缺乏将干细胞长期保持在未分化状态的方法。
Weizmann Institute of Science (Rehovot, Israel) 的研究人员使用小鼠和人类细胞进行研究，努力解决此问题。他们尤其感兴趣建立一种技术，将人类的 iPS 细胞保持在最早期基态，以模拟小鼠的干细胞行为，后者能更长时间自然的保持未分化状态。
研究人员在 2013 年 10 月 30 日的《自然杂志》(Nature) 网络版中报道，已成功确立了指定条件，以便于将已经成为始发态人类胚胎干细胞的细胞衍生为未经基因改良的人类基态多能干细胞、经由 iPS 细胞重新编程从体细胞衍生为未经基因改良的人类基态多能干细胞，或直接从囊胚泡衍生为未经基因改良的人类基态多能干细胞。新的基态多能细胞保留了与小鼠基态胚胎干细胞高度相似的分子特性和功能特性，并有别于普通的始发人类多能干细胞。
Related Links:
Weizmann Institute of Science
诱导多能干细胞形成的方法通常为：向诸如皮肤细胞的此类成人细胞基因组中插入 4 个基因，然后使用鸡尾酒式组合的生长因子培养改良的细胞。然后分化的细胞还原为胚胎干细胞类似状态，而不是成为多种不同细胞类型的成熟细胞。此问题的症结在于，缺乏将干细胞长期保持在未分化状态的方法。
Weizmann Institute of Science (Rehovot, Israel) 的研究人员使用小鼠和人类细胞进行研究，努力解决此问题。他们尤其感兴趣建立一种技术，将人类的 iPS 细胞保持在最早期基态，以模拟小鼠的干细胞行为，后者能更长时间自然的保持未分化状态。
研究人员在 2013 年 10 月 30 日的《自然杂志》(Nature) 网络版中报道，已成功确立了指定条件，以便于将已经成为始发态人类胚胎干细胞的细胞衍生为未经基因改良的人类基态多能干细胞、经由 iPS 细胞重新编程从体细胞衍生为未经基因改良的人类基态多能干细胞，或直接从囊胚泡衍生为未经基因改良的人类基态多能干细胞。新的基态多能细胞保留了与小鼠基态胚胎干细胞高度相似的分子特性和功能特性，并有别于普通的始发人类多能干细胞。
Related Links:
Weizmann Institute of Science
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Clinical Chemistry System
P780
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Latest Biotech News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more